AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ)

CUSIP: 00973N102

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
53,160,953
Total 13F shares
11,160,282
Share change
+4,395,006
Total reported value
$71,421,311
Price per share
$6.40
Number of holders
74
Value change
+$28,509,937
Number of buys
47
Number of sells
22

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00973N102?
CUSIP 00973N102 identifies AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
2%
1,078,218
$6,264,000 31 Mar 2019
13F
SILVERBACK ASSET MANAGEMENT LLC
13F
Company
1.5%
809,056
$4,701,000 31 Mar 2019
13F
HERALD INVESTMENT MANAGEMENT Ltd
13F
Company
1.1%
578,636
$3,361,000 31 Mar 2019
13F
NORTH RUN CAPITAL, LP
13F
Company
0.58%
310,000
$1,801,000 31 Mar 2019
13F
First Eagle Investment Management, LLC
13F
Company
0.57%
304,490
$1,769,000 31 Mar 2019
13F
MISSION WEALTH MANAGEMENT, LP
13F
Company
0.53%
279,987
$1,627,000 31 Mar 2019
13F
UBS Group AG
13F
Company
0.47%
251,470
$1,461,000 31 Mar 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.45%
237,074
$1,377,000 31 Mar 2019
13F
Financial Advocates Investment Management
13F
Company
0.41%
217,700
$1,265,000 31 Mar 2019
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.4%
215,099
$1,249,000 31 Mar 2019
13F
SALEM INVESTMENT COUNSELORS INC
13F
Company
0.28%
149,275
$1,175,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.37%
196,817
$1,143,000 31 Mar 2019
13F
Millrace Asset Group, Inc.
13F
Company
0.33%
172,887
$1,004,000 31 Mar 2019
13F
BARCLAYS PLC
13F
Company
0.31%
164,913
$958,000 31 Mar 2019
13F
BlackRock Finance, Inc.
13F
Company
0.29%
151,820
$882,000 31 Mar 2019
13F
NEEDHAM INVESTMENT MANAGEMENT LLC
13F
Company
0.25%
135,000
$784,000 31 Mar 2019
13F
Laurion Capital Management LP
13F
Company
0.25%
132,038
$767,000 31 Mar 2019
13F
D.A. DAVIDSON & CO.
13F
Company
0.21%
109,000
$633,000 31 Mar 2019
13F
PERKINS CAPITAL MANAGEMENT INC
13F
Company
0.19%
103,050
$599,000 31 Mar 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
102,486
$594,000 31 Mar 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.16%
82,749
$481,000 31 Mar 2019
13F
FNY Investment Advisers, LLC
13F
Company
0.15%
78,739
$457,000 31 Mar 2019
13F
BENJAMIN F. EDWARDS & COMPANY, INC.
13F
Company
0.15%
78,400
$456,000 31 Mar 2019
13F
BOARDMAN BAY CAPITAL MANAGEMENT LLC
13F
Company
0.12%
65,237
$379,000 31 Mar 2019
13F
NORTHERN TRUST CORP
13F
Company
0.1%
55,460
$322,000 31 Mar 2019
13F
Quad Capital Management Advisors LLC
13F
Company
0.1%
53,489
$311,000 31 Mar 2019
13F
Tibra Equities Europe Ltd
13F
Company
0.1%
53,345
$310,000 31 Mar 2019
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.09%
50,000
$291,000 31 Mar 2019
13F
ExodusPoint Capital Management, LP
13F
Company
0.09%
49,168
$286,000 31 Mar 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
48,504
$282,000 31 Mar 2019
13F
EATON VANCE MANAGEMENT
13F
Company
0.09%
45,782
$266,000 31 Mar 2019
13F
Bank of New York Mellon Corp
13F
Company
0.08%
43,409
$252,000 31 Mar 2019
13F
CITIGROUP INC
13F
Company
0.08%
42,955
$250,000 31 Mar 2019
13F
CONNORS INVESTOR SERVICES INC
13F
Company
0.07%
37,406
$217,000 31 Mar 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.06%
34,400
$200,000 31 Mar 2019
13F
HBK Sorce Advisory LLC
13F
Company
0.06%
32,158
$187,000 31 Mar 2019
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.05%
28,825
$167,000 31 Mar 2019
13F
BlueCrest Capital Management Ltd
13F
Company
0.05%
25,660
$149,000 31 Mar 2019
13F
IHT Wealth Management, LLC
13F
Company
0.04%
18,917
$110,000 31 Mar 2019
13F
Marshall Wace North America L.P.
13F
Company
0.03%
16,730
$97,000 31 Mar 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
15,800
$92,000 31 Mar 2019
13F
Jump Trading, LLC
13F
Company
0.03%
15,100
$88,000 31 Mar 2019
13F
STATE STREET CORP
13F
Company
0.02%
12,981
$75,000 31 Mar 2019
13F
MORGAN STANLEY
13F
Company
0.02%
12,691
$74,000 31 Mar 2019
13F
Verition Fund Management LLC
13F
Company
0.02%
12,264
$71,000 31 Mar 2019
13F
WINTON GROUP Ltd
13F
Company
0.02%
11,934
$69,000 31 Mar 2019
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.02%
11,902
$69,000 31 Mar 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
11,857
$69,000 31 Mar 2019
13F
Jefferies Group LLC
13F
Company
0.02%
11,500
$67,000 31 Mar 2019
13F
ROYAL BANK OF CANADA
13F
Company
0.02%
8,120
$47,000 31 Mar 2019
13F

Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q2 2019

As of 30 Jun 2019, AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,160,282 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, NORTH RUN CAPITAL, LP, Blackcrane Capital, LLC, Herald Investment Management Ltd, SILVERBACK ASSET MANAGEMENT LLC, STATE STREET CORP, MYDA Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, and DEUTSCHE BANK AG\. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
61
Q2 2019 holders
74
Holder diff
13
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.